367 related articles for article (PubMed ID: 30831080)
1. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
3. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.
Yuan X; Huang Y; Guo M; Hu X; Li P
J Ovarian Res; 2021 Jan; 14(1):6. PubMed ID: 33413565
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
6. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
8. Promoting roles of long non-coding RNA FAM83H-AS1 in bladder cancer growth, metastasis, and angiogenesis through the c-Myc-mediated ULK3 upregulation.
Liu B; Gao W; Sun W; Li L; Wang C; Yang X; Liu J; Guo Y
Cell Cycle; 2020 Dec; 19(24):3546-3562. PubMed ID: 33289601
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer.
Zhang J; Feng S; Su W; Bai S; Xiao L; Wang L; Thomas DG; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Beer DG; Guo YM; Chen G
Sci Rep; 2017 Feb; 7():42819. PubMed ID: 28198463
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis.
Feng B; Wang G; Liang X; Wu Z; Wang X; Dong Z; Guo Y; Shen S; Liang J; Guo W
J Cell Mol Med; 2020 Aug; 24(16):8962-8976. PubMed ID: 32583631
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FAM83H-AS1 Contributes to the Radio-resistance and Proliferation in Liver Cancer through Stability FAM83H Protein.
Jiang X; Lan Y; Zhang Y; Dong Y; Song T
Recent Pat Anticancer Drug Discov; 2024; 19(3):316-327. PubMed ID: 37132310
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability.
Xu Q; Lin YB; Li L; Liu J
Biochem Biophys Res Commun; 2020 Jun; 526(4):857-864. PubMed ID: 32278547
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.
Zhou M; Pan S; Qin T; Zhao C; Yin T; Gao Y; Liu Y; Zhang Z; Shi Y; Bai Y; Gong J; Guo X; Wang M; Qin R
J Exp Clin Cancer Res; 2022 Sep; 41(1):288. PubMed ID: 36171592
[TBL] [Abstract][Full Text] [Related]
16. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).
Bi YY; Shen G; Quan Y; Jiang W; Xu F
J Cell Physiol; 2018 Nov; 233(11):8896-8907. PubMed ID: 29870057
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer.
Wang A; Bao Y; Wu Z; Zhao T; Wang D; Shi J; Liu B; Sun S; Yang F; Wang L; Qu L
Cell Death Dis; 2019 Feb; 10(3):154. PubMed ID: 30770799
[TBL] [Abstract][Full Text] [Related]
19. Functional Role of a Novel Long Noncoding RNA
Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
[No Abstract] [Full Text] [Related]
20. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.
Gu H; Lin R; Zheng F; Zhang Q
J Mol Histol; 2021 Feb; 52(1):31-44. PubMed ID: 33099720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
